Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 18 (RPL7AP18)

Target: RPL7AP18
Molecular classification: Other, Pseudogene

Overview

RPL7AP18 is a processed pseudogene derived from the ribosomal protein L7a gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they arise from duplication or retrotransposition events. RPL7AP18 does not produce a protein and has no known biological or disease-related function. It is distinct and should not be confused with the functional ribosomal protein L7a (RPL7A), which is a structural component of the 60S ribosomal subunit and involved in protein synthesis.

Other names: Ribosomal protein L7a pseudogene 18RPL7AP18

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 18 (RPL7AP18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 18 (RPL7AP18).

Explore the full profile